Q75V66 (ANO5_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 81.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Anoctamin-5 Alternative name(s): Gnathodiaphyseal dysplasia 1 protein Transmembrane protein 16E | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 913 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Does not exhibit calcium-activated chloride channel (CaCC) activity. |
| Subcellular location | Endoplasmic reticulum membrane; Multi-pass membrane protein. Cell membrane. Note: Co-localized with CALR/calreticulin. Shows an intracellular localization according to Ref.6. Ref.1 Ref.3 Ref.6 Ref.8 |
| Tissue specificity | Highly expressed in brain, heart, kidney, lung, and skeletal muscle. Weakly expressed in bone marrow, fetal liver, placenta, spleen, thymus, osteoblasts and periodontal ligament cells. Ref.1 Ref.2 |
| Involvement in disease | Gnathodiaphyseal dysplasia (GDD) [MIM:166260]: Rare skeletal syndrome characterized by bone fragility, sclerosis of tubular bones, and cemento-osseous lesions of the jawbone. Patients experience frequent bone fractures caused by trivial accidents in childhood; however the fractures heal normally without bone deformity. The jaw lesions replace the tooth-bearing segments of the maxilla and mandible with fibrous connective tissues, including various amounts of cementum-like calcified mass, sometimes causing facial deformities. Patients also have a propensity for jaw infection and often suffer from purulent osteomyelitis-like symptoms, such as swelling of and pus discharge from the gums, mobility of the teeth, insufficient healing after tooth extraction and exposure of the lesions into the oral cavity. Limb-girdle muscular dystrophy 2L (LGMD2L) [MIM:611307]: An autosomal recessive degenerative myopathy characterized by proximal weakness, weakness of the hip and shoulder girdles and prominent asymmetrical quadriceps femoris and biceps brachii atrophy. Miyoshi muscular dystrophy 3 (MMD3) [MIM:613319]: A late-onset muscular dystrophy characterized by distal muscle weakness of the lower limbs, calf muscle discomfort and weakness, quadriceps atrophy. Muscle weakness and atrophy may be asymmetric. |
| Miscellaneous | The term 'anoctamin' was coined because these channels are anion selective and have eight (OCT) transmembrane segments. There is some dissatisfaction in the field with the Ano nomenclature because it is not certain that all the members of this family are anion channels or have the 8-transmembrane topology. |
| Sequence similarities | Belongs to the anoctamin family. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cell membrane Endoplasmic reticulum Membrane |
| Coding sequence diversity | Polymorphism |
| Disease | Disease mutation Limb-girdle muscular dystrophy Osteogenesis imperfecta |
| Domain | Transmembrane Transmembrane helix |
| PTM | Glycoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Cellular_component | endoplasmic reticulum membrane Inferred from electronic annotation. Source: UniProtKB-SubCell integral to membraneInferred from electronic annotation. Source: UniProtKB-KW intracellularInferred from direct assay Ref.6. Source: UniProtKB plasma membraneInferred from electronic annotation. Source: UniProtKB-SubCell |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 913 | 913 | Anoctamin-5 | PRO_0000191755 | |||||
Regions | |||||||||
| Topological domain | 1 – 299 | 299 | Cytoplasmic Potential | ||||||
| Transmembrane | 300 – 320 | 21 | Helical; Potential | ||||||
| Topological domain | 321 – 380 | 60 | Extracellular Potential | ||||||
| Transmembrane | 381 – 401 | 21 | Helical; Potential | ||||||
| Topological domain | 402 – 462 | 61 | Cytoplasmic Potential | ||||||
| Transmembrane | 463 – 483 | 21 | Helical; Potential | ||||||
| Topological domain | 484 – 511 | 28 | Extracellular Potential | ||||||
| Transmembrane | 512 – 532 | 21 | Helical; Potential | ||||||
| Topological domain | 533 – 557 | 25 | Cytoplasmic Potential | ||||||
| Transmembrane | 558 – 578 | 21 | Helical; Potential | ||||||
| Topological domain | 579 – 679 | 101 | Extracellular Potential | ||||||
| Transmembrane | 680 – 700 | 21 | Helical; Potential | ||||||
| Topological domain | 701 – 732 | 32 | Cytoplasmic Potential | ||||||
| Transmembrane | 733 – 753 | 21 | Helical; Potential | ||||||
| Topological domain | 754 – 834 | 81 | Extracellular Potential | ||||||
| Transmembrane | 835 – 855 | 21 | Helical; Potential | ||||||
| Topological domain | 856 – 913 | 58 | Cytoplasmic Potential | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 335 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 366 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 380 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 768 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 778 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 791 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Natural variant | 58 | 1 | R → W Found in a patient with hyper-CK-emia and a neurasthenic syndrome; unknown pathological significance. Ref.10 | VAR_068247 | |||||
| Natural variant | 231 | 1 | G → V in LGMD2L. Ref.9 | VAR_063582 | |||||
| Natural variant | 322 | 1 | L → F. Corresponds to variant rs7481951 [ dbSNP | Ensembl ]. | VAR_052339 | |||||
| Natural variant | 356 | 1 | C → G in GDD; decreases cell adhesion and changes cell morphology to a round shape. Ref.1 | VAR_023524 | |||||
| Natural variant | 356 | 1 | C → R in GDD; decreases cell adhesion and changes cell morphology to a round shape. Ref.1 | VAR_023525 | |||||
| Natural variant | 655 | 1 | W → C in MMD3; unknown pathological significance. Ref.10 | VAR_068248 | |||||
| Natural variant | 758 | 1 | R → C in MMD3. Ref.9 | VAR_063583 | |||||
| Natural variant | 882 | 1 | N → K. Corresponds to variant rs34969327 [ dbSNP | Ensembl ]. | VAR_052340 | |||||
Sequences
| ||||||||||||||||||
References
| [1] | "The novel gene encoding a putative transmembrane protein is mutated in gnathodiaphyseal dysplasia (GDD)." Tsutsumi S., Kamata N., Vokes T.J., Maruoka Y., Nakakuki K., Enomoto S., Omura K., Amagasa T., Nagayama M., Saito-Ohara F., Inazawa J., Moritani M., Yamaoka T., Inoue H., Itakura M. Am. J. Hum. Genet. 74:1255-1261(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, SUBCELLULAR LOCATION, VARIANTS GDD GLY-356 AND ARG-356, CHARACTERIZATION OF VARIANTS GDD GLY-356 AND ARG-356. Tissue: Skeletal muscle. |
| [2] | "Identification and characterization of TMEM16E and TMEM16F genes in silico." Katoh M., Katoh M. Int. J. Oncol. 24:1345-1349(2004) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [3] | "Expression and function of epithelial anoctamins." Schreiber R., Uliyakina I., Kongsuphol P., Warth R., Mirza M., Martins J.R., Kunzelmann K. J. Biol. Chem. 285:7838-7845(2010) [PubMed] [Europe PMC] [Abstract] Cited for: ABSENCE OF CALCIUM-ACTIVATED CHLORIDE CHANNEL ACTIVITY, SUBCELLULAR LOCATION. |
| [4] | "Physiological roles and diseases of Tmem16/Anoctamin proteins: are they all chloride channels?" Duran C., Hartzell H.C. Acta Pharmacol. Sin. 32:685-692(2011) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [5] | "Anoctamins." Kunzelmann K., Tian Y., Martins J.R., Faria D., Kongsuphol P., Ousingsawat J., Thevenod F., Roussa E., Rock J., Schreiber R. Pflugers Arch. 462:195-208(2011) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [6] | "ANOs 3-7 in the anoctamin/Tmem16 Cl- channel family are intracellular proteins." Duran C., Qu Z., Osunkoya A.O., Cui Y., Hartzell H.C. Am. J. Physiol. 302:C482-C493(2012) [PubMed] [Europe PMC] [Abstract] Cited for: ABSENCE OF CALCIUM-ACTIVATED CHLORIDE CHANNEL ACTIVITY, SUBCELLULAR LOCATION. |
| [7] | "The anoctamin (TMEM16) gene family: calcium-activated chloride channels come of age." Winpenny J.P., Gray M.A. Exp. Physiol. 97:175-176(2012) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [8] | "Anoctamins are a family of Ca2+ activated Cl- channels." Tian Y., Schreiber R., Kunzelmann K. J. Cell Sci. 125:4991-4998(2012) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [9] | "Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies." Bolduc V., Marlow G., Boycott K.M., Saleki K., Inoue H., Kroon J., Itakura M., Robitaille Y., Parent L., Baas F., Mizuta K., Kamata N., Richard I., Linssen W.H., Mahjneh I., de Visser M., Bashir R., Brais B. Am. J. Hum. Genet. 86:213-221(2010) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT LGMD2L VAL-231, VARIANT MMD3 CYS-758. |
| [10] | "Novel ANO5 mutations causing hyper-CK-emia, limb girdle muscular weakness and Miyoshi type of muscular dystrophy." Schessl J., Kress W., Schoser B. Muscle Nerve 45:740-742(2012) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT TRP-58, VARIANT MMD3 CYS-655. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AB125267 mRNA. Translation: BAD17859.1. |
| IPI | IPI00412694. |
| RefSeq | NP_001136121.1. NM_001142649.1. NP_998764.1. NM_213599.2. |
| UniGene | Hs.154329. |
3D structure databases | |
| ProteinModelPortal | Q75V66. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 9606.ENSP00000315371. |
PTM databases | |
| PhosphoSite | Q75V66. |
Polymorphism databases | |
| DMDM | 74749827. |
Proteomic databases | |
| PaxDb | Q75V66. |
| PRIDE | Q75V66. |
Protocols and materials databases | |
| DNASU | 203859. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000324559; ENSP00000315371; ENSG00000171714. |
| GeneID | 203859. |
| KEGG | hsa:203859. |
| UCSC | uc001mqi.2. human. |
Organism-specific databases | |
| CTD | 203859. |
| GeneCards | GC11P022172. |
| HGNC | HGNC:27337. ANO5. |
| MIM | 166260. phenotype. 608662. gene. 611307. phenotype. 613319. phenotype. |
| neXtProt | NX_Q75V66. |
| Orphanet | 206549. Autosomal recessive limb-girdle muscular dystrophy type 2L. 53697. Gnathodiaphyseal dysplasia. 45448. Miyoshi myopathy. |
| PharmGKB | PA164715641. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG320103. |
| HOGENOM | HOG000006509. |
| HOVERGEN | HBG069519. |
| InParanoid | Q75V66. |
| OMA | FTTCRYR. |
| OrthoDB | EOG4M397V. |
| PhylomeDB | Q75V66. |
Gene expression databases | |
| Bgee | Q75V66. |
| CleanEx | HS_ANO5. |
| Genevestigator | Q75V66. |
| GermOnline | ENSG00000171714. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR007632. Anoctamin. [Graphical view] |
| PANTHER | PTHR12308. PTHR12308. 1 hit. |
| Pfam | PF04547. Anoctamin. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 203859. |
| NextBio | 90462. |
| SOURCE | Search... |
Entry information
| Entry name | ANO5_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q75V66 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 11 Human chromosome 11: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
